02.11.2018 • NewsDaelimElaine BurridgeMa’aden

Ma’aden Awards Phosphate Contract to Daelim

Ma’aden Awards Phosphate Contract to Daelim (c) Daelim
Ma’aden Awards Phosphate Contract to Daelim (c) Daelim

Saudi Arabian Mining Company (Ma’aden) has awarded an engineering, procurement and construction (EPC) contract to South Korea’s Daelim for the first plant to be built as part of its third large-scale phosphate complex at Ras Al-Khair on Saudi Arabia’s east coast.

Daelim Industrial and Saudi Daelim will jointly perform EPC services on the plant, which will produce 1.1 million t/y of ammonia. The project will take 38 months to implement.

The complex, known as Phosphate 3, will increase Ma’aden’s phosphate capacity by 3 million t/y to a total of 9 million t/y, making the Kingdom the world’s third-largest producer of phosphate fertilizer and the second-largest exporter.

Ma’aden said the overall project, which is expected to cost $6.4 billion, will be built in stages and phased in by 2024. It will generate non-oil GDP growth of $6.7 billion and create approximately 7,000 direct and indirect jobs.

Daelim recently provided EPC services on an ammonia plant for Ma’aden Waad Al-Shamal Phosphate Company, a joint venture between Ma’aden, SABIC and US fertilizer group Mosaic. The 1.1 million t/y ammonia facility, one of seven plants at the phosphate complex that is also located at Ras Al-Khair, started commercial production in 2017.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.